ALLAKOS INC.

SAN CARLOS, CA How do I update this listing?

Create Email Alert

Allakos is based out of San Carlos. Allakos Inc. operates as a clinical stage bio-technology company. The Company discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory, and proliferative diseases. Allakos serves customers in the United States. The firm last filed a Form D notice of exempt offering of securities on 2017-12-18. The notice included securities offered of Equity

Contact Info

allakos inc.
825 INDUSTRIAL ROAD
SAN CARLOS CA    94070

Business Phone: 650-597-5002
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2017-12-18 D BIOTECHNOLOGY Equity 100,141,456 100,141,456 0
2015-03-25 D/A PHARMACEUTICALS Equity 47,000,008 27,949,545 19,050,463
2014-08-27 D/A PHARMACEUTICALS Equity 41,999,994 24,545,452 17,454,542
2012-12-20 D PHARMACEUTICALS Equity 31,999,989 9,999,997 21,999,992
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
CHRISTOPHER BEBBINGTON subscription required
    EXECUTIVE OFFICER DIRECTOR
NENAD TOMASEVIC subscription required
    EXECUTIVE OFFICER
ROBERT ALEXANDER subscription required
    DIRECTOR
JOHN MCKEARN subscription required
    DIRECTOR
PETER MOLDT subscription required
    DIRECTOR
FARAH CHAMPSI subscription required
    DIRECTOR
ALEJANDRO DORENBAUM subscription required
    EXECUTIVE OFFICER
ADAM TOMASI subscription required
    EXECUTIVE OFFICER
PAUL WALKER subscription required
    DIRECTOR
DAN JANNEY subscription required
    DIRECTOR
STEVE JAMES subscription required
    DIRECTOR

Elevate your investments